Saifuyuzu

4892.TPharmaceutical

Filed as Cyfuse Biomedical K.K. (2023-03–2026-08)

Key numbers · FY ended 2025-12

Revenue¥231m+324.3% YoY Operating income−¥828m—Total assets¥4.3bn+21.3% YoY EPS (basic)¥-86.78+19.9% YoY

Full financial history and reports →

Stock price4892 · View chart ↗

Open the price chart on TradingView.

Latest filings

Tue, May 12 · JST1 filing

16:365% STAKESaifuyuzu · SBI Ventures Two Co., Ltd. + 2 joint holders · 9.92% → 7.71%−2.21pp

Tue, Apr 28 · JST1 filing

16:325% STAKESaifuyuzu · Shizuka Akieda · 8.33% → 7.31%−1.02pp

Mon, Apr 27 · JST1 filing

16:265% STAKESaifuyuzu · SBI Ventures Two Co., Ltd. + 2 joint holders · 10.64% → 9.92%−0.72pp

Fri, Jan 23 · JST1 filing

16:495% STAKESaifuyuzu · SBI Ventures Two Co., Ltd. + 2 joint holders · 11.67% → 10.64%−1.03pp

Tue, Sep 2 · JST1 filing

16:125% STAKESaifuyuzu · SBI SECURITIES Co., Ltd. + 2 joint holders · 15.38% → 14.26%−1.12pp

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
Shizuka Akieda	7.31%	-1.02pp	2026-04-28
Masahiro Sanjo	6.74%	+1.26pp	2025-05-07

Each holder's own ratio from its most recent large-shareholding report.